Organized by Sansure Biotech Inc. , the national demonstration center for genetic testing technology applications has been approved by NDRC and becomes one of the first genetic testing technology application demonstration centers in China.

It is reported that the national demonstration center for genetic testing technology applications is a strategic part of NDRC’s New Healthcare Technology Project. NDRC is going to build 30 genetic testing technology application demonstration centers all around China, in order to promote the use of advanced genetic testing technologies in the prevention of Birth defects diseases, hereditary diseases, tumors, cardiovascular and cerebrovascular diseases and infectious diseases.

Sansure Biotech Inc. is established in 2008 by professor Dai Lizhong, a member of China’s 1,000 Talents Plan. It’s a total solution provider based on genetic testing technologies and covers R＆D, manufacture, sales and technology service of IVD products and reagents.

As a total solution provider in genetic testing industry, Sansure Biotech Inc. has many state-of-the-art talents and self-developed technologies. Now Sansure has over 10 national major innovation awards, over 40 patents for inventions and more than 150 kinds of products. Its products are used in 700 hospitals in China and are sold to more than 30 countries all over the globe. It’s one of the industry leaders in China genetic testing industry and is leading the industry to precision, simplification, automation and systematization.